Effect of Nutrition Ingredients on Microbiota Modulation

NCT03668964 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2020-03-30

No results posted yet for this study

Summary

The objective of this study is to evaluate in healthy volunteers the time-dependent effect of daily consumption for four weeks of six different nutrition ingredients on relative abundance of microbial taxa in fecal samples. Second, the study looks at the time-dependent effect of six different nutrition ingredients on alpha and beta diversity of microbiota in fecal samples. Moreover, the time-dependent effect of six different nutrition ingredients on gastrointestinal symptoms and quality of life will be measured.

Conditions

  • Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

Vitamin B2

One capsule of 75 mg Vitamin B2 once a day for 4 weeks

DIETARY_SUPPLEMENT

Vitamin C

One capsule of 500 mg Vitamin C once a day for 4 weeks

DIETARY_SUPPLEMENT

Vitamin B2 + C

One capsule of of 75 mg Vitamin B2 plus 500 mg Vitamin C once a day for 4 weeks

DIETARY_SUPPLEMENT

Vitamin A

One capsule of 250 µg Vitamin A once a day for 4 weeks

DIETARY_SUPPLEMENT

Vitamin D3

One capsule of 60 µg Vitamin D3 once a day for 4 weeks

DIETARY_SUPPLEMENT

Vitamin E

One capsule of 100 mg Vitamin E once a day for 4 weeks

DIETARY_SUPPLEMENT

Placebo

One capsule of 575 mg microcrystalline cellulose once a day for 4 weeks

Sponsors & Collaborators

  • Atlantia Food Clinical Trials

    collaborator INDUSTRY
  • DSM Nutritional Products, Inc.

    lead INDUSTRY

Principal Investigators

  • Timothy Dinan, Prof · Cork University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-20
Primary Completion
2019-07-15
Completion
2019-07-15

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03668964 on ClinicalTrials.gov